Radium-223 Calibration

Similar documents
Radium-223 Therapy: Handling & Radiation Safety Issues

Quality Assurance Testing of AtomLab Dose Calibrators

P O L Y T E C R.M. S.R.L.

4. CHEMICAL, PHYSICAL, AND RADIOLOGICAL INFORMATION

Antoine Henri Becquerel was born in Paris on December 15, 1852

Experiment 10. Radioactive Decay of 220 Rn and 232 Th Physics 2150 Experiment No. 10 University of Colorado

Syringe Calibration Factors and Volume Correction Factors for the NPL Secondary Standard Radionuclide Calibrator.

Ionizing Radiation, Czech Republic, CMI (Czech Metrology Institute)

1. In the general symbol cleus, which of the three letters. 2. What is the mass number of an alpha particle?

Medical Physics and Radioactivity

EPA Radionuclides Rule and the RadNet Program

Chemistry 1000 Lecture 2: Nuclear reactions and radiation. Marc R. Roussel

Main properties of atoms and nucleus

Radiation and the Universe Higher Exam revision questions and answers

Unit 1 Practice Test. Matching

Bone Metastases. rom Prostate Cancer. Øyvind S. Bruland Professor, Dept. Of Oncology. Alpharadin R 223 Ra

Noble Gases. Outline Nobel Gas Elements Radon and Health Chemistry Homework

ORTEC DET-SW-UPG. Latest Software Features. Ease of Use. Source Location with the Detective V3 Software

Novel Radionuclide Therapies in Oncology : Promising Area in the Field of Nuclear Medicine

M. Marengo. Medical Physics Department University Hospital S.Orsola Malpighi, Bologna

Qualitätsmanagement-Handbuch

PHYA5/1. General Certificate of Education Advanced Level Examination June Unit 5 Nuclear and Thermal Physics Section A

Azeri, Chirag & Gunashli Full Field Development Phase 3 Environmental & Socio-economic Impact Assessment. A10.1 Introduction...

RADON Although radon is agas, its decay products are not, and they occur either as unattached

[2] At the time of purchase of a Strontium-90 source, the activity is Bq.

University of Missouri and MU Research Reactor Center

COMPENDIUM OF EPA-APPROVED ANALYTICAL METHODS FOR MEASURING RADIONUCLIDES IN DRINKING WATER

Homework #10 (749508)

2 ATOMIC SYSTEMATICS AND NUCLEAR STRUCTURE

A radiation weighting factor is an estimate of the effectiveness per unit dose of the given radiation relative a to low-let standard.

Radiopharmaceuticals that can be used for alleviating pain caused by bone metastases:

INFO-0545 RADIOISOTOPE SAFETY MONITORING FOR RADIOACTIVE CONTAMINATION

Radiation Detection and Measurement

A running centre for radioisotope production: present and future perspectives

Physics 1104 Midterm 2 Review: Solutions

Structure and Properties of Atoms

PROFORMA ACCEPTANCE / QUALITY ASSURANCE TESTS OF REMOTE AFTERLOADING BRACHYTHERAPY UNIT

For convenience, we may consider an atom in two parts: the nucleus and the electrons.

Eckert & Ziegler Reference & Calibration Sources

Lesson 43: Alpha, Beta, & Gamma Decay

RESULTS OBTAINED IN MEASUREMENTS OF Rn-222 WITH THE ROMANIAN STANDARD SYSTEM*

Treating Thyroid Cancer using I-131 Maximum Tolerable Dose Method

Radiation Monitoring System DLMon

Autoradiograph of Ra-223

Nuclear Fusion and Radiation

RADIO PHARMACEUTICAL PROCEDURE PROTOCOL: QUADRAMET

Atomic and Nuclear Physics Laboratory (Physics 4780)

Table 1. Uranium-238 Decay Chain

The objective of this chapter is to provide criteria with which to assess the safety of

Chapter 17: Radioactivity and Nuclear Chemistry

Nuclear Physics and Radioactivity

Perspectives of a method for measuring soil-gas radon by an opened counting vial

22.1 Nuclear Reactions

Genetically dependent nuclides

Objectives 404 CHAPTER 9 RADIATION

Radioactivity III: Measurement of Half Life.

The decay of progeny continues until stable, non-radioactive progeny are formed. At each step in the decay process, radiation is released.

1/4 Specifications Hidex 300 SL automatic TDCR liquid scintillation counter

UNIVERSITY IN CLUJ Tamás NÉDA, Ildikó MÓCSY, Szende TONK Sapientia University Cluj, Environmental Science Department

Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material)

Selection, use and maintenance of portable monitoring instruments

Decay of Radioactivity. Radioactive decay. The Math of Radioactive decay. Robert Miyaoka, PhD. Radioactive decay:

CONCENTRATION OF U-238, U-235, RA-226, TH-232 AND K- 40 FOR SOME GRANITE SAMPLES IN EASTERN DESERT OF EGYPT.

NOTES ON The Structure of the Atom

Level 3 Science, 2008

Seminar 7. Medical application of radioisotopes - radiotherapy

Annual effective dose and concentration levels of gross α and β in Turkish market tea

Basics of Nuclear Physics and Fission

Individual Monitoring Services (IMS) for External and Internal Exposures

USE OF IONIZING RADIATION IN THE TEACHING OF PHYSICS AND CHEMISTRY

Industrial tracers - Finding leaks and blockages

Environmental Health and Safety Radiation Safety. Module 1. Radiation Safety Fundamentals

METASTASES TO THE BONE

A Comparison of an HPGe-based and NaI-based Radionuclide Identifier (RID) for Radioactive Materials

Nuclear Science Merit Badge Workbook

Society of Nuclear Medicine Procedure Guideline for Palliative Treatment of Painful Bone Metastases

Introduction to Nuclear Physics

Lab 2. Spectrophotometric Measurement of Glucose

Basic Nuclear Concepts

Natural radioactivity in waste from former non-uranium mining areas in Norway

ACCELERATORS AND MEDICAL PHYSICS 2

Isotopes used in Biology

Comparison of natural radioactivity removal methods for drinking water supplies: A review

Waste Management 04 Conference, February 29 - March 4, 2004, Tucson, AZ Copyright WM Symposia, Inc. All Rights Reserved. Reprinted with permission.

The effects of radiation on the body can be divided into Stochastic (random) effects and deterministic or Non-stochastic effects.

SCH 3UI Unit 2 Outline Up to Quiz #1 Atomic Theory and the Periodic Table

Thomas de los Reyes PGY 1 Department of Urologic Sciences University of British Columbia. Meet Mr. S

Measurement of Germanium Detector Efficiency

Use of the VALIDATOR Dosimetry System for Quality Assurance and Quality Control of Blood Irradiators

Alarm Response Guidelines for Radiation Portal Monitoring Systems

Sarasota County Schools

Nuclear Physics. Nuclear Physics comprises the study of:

Clinical Image Gallery: Symbia xspect

Nuclear medicine. Answering your questions

BY UV SPECTROPHOTOMETRY

Study the Quality Assurance of Conventional X-ray Machines Using Non Invasive KV meter

GAMMA-RAY SPECTRA REFERENCES

W. C. Reinig. Savannah River Laboratory E. I. du Pent de Nemours and Company Aiken, South Carolina 298o1

short mean lives), emitting alpha particles, which have a high LET. Thus radon causes

Introduction to Geiger Counters

Transcription:

Radium-223 Calibration Sue Hooper Principal Physicist Nuclear Medicine Velindre NHS Trust

What is Ra-223? Ra-223 (Alpharadin) is an alpha emitting radionuclide -supplied by Algeta ASA in Norway 227 Ac 227 Th 223 Ra

Why use Ra-223? It is being used in a phase II, multicentre study for the palliation of painful bone metastases in hormone refractory prostate cancer patients cf Sr-89 (Metastron) and Sm-153 (Quadramet) - both β emitters

Range in tissue Tissue range for 223 Ra < 100 µm (α) Cf Tissue range for 89 Sr < 8mm (β) Quality F actor: α particles = 20 γ rays & β particles =1

Activities of Ra-223 involved Patients are entered into one of four randomisation arms: 5, 25, 50 or 100 kbq/kg

Physical Properties of T ½ = 11.43 days Ra-223 α energy (average) = 5.78 MeV (accounts for 93.5% of emitted energy); <4% as β particles; <2% as γ radiation β energy/decay: 1MeV (ave) γ energy/decay: 0.4 MeV γ energy: 269 kev (13.6%) 154 kev (6.04%) 324 kev (3.9%)

Decay Scheme of Ra-223 223 Ra 11.43 d 219 Rn 3.96 s 215 Po 1.78 ms α, 5.78 ΜeV α, 6.88 MeV Combined energy for the complete decay of Ra-223 & daughters = 28MeV 211 Pb 36.1 m α, 7.53 MeV β -, 0.45 MeV Some γ (0.9 MeV total) is also emitted 211 Bi 2.17 m α (99.727 %), 6.68 MeV β - (0.273 %), 0.01 MeV 207 Tl 4.77 m β -, 0.49 MeV 211 Po 516 ms α, 7.59 MeV Courtesy of Algeta 207 Pb stable

Container for Ra-223 20 ml glass vial Conc 500 or 1000 kbq/ml Maximum activity in vial =23 MBq Dose rate from unshielded vial outer wall: 100µSv/h/MBq 10cm from vial : 6µSv/h/MBq 100 cm from vial: 0.06 µsv/h/mbq

Calibration Procedure (SOP) The company send out a SOP Dial setting of Radioisotope Dose Calibrators for measurement of the radioisotope Radium-223 at clinical centres prior to clinical trials with Alpharadin.

Calibration Procedure (SOP) 1. Purpose - to find the dial setting for the Dose Calibrator! 2. Responsibility and Authority - tells you to follow SOP and return the results 3. Definitions None

Calibration Procedure (SOP) 4. Procedure : Scheme 1 is used to decay correct the activity in the Ra-223 solution Scheme 2 is used to document the affirmative measurements for the dial setting (more detail to follow)

Calibration Procedure (SOP) Perform standard QA & bkgd checks for calibrator Read stated activity of Ra-223 on label of vial. Use supplied Volume Correction chart to correct the stated activity for decay to the measuring time. Corr act = A c

Vol corr chart Days from ref date Vol. x factor (V mf ) -5 0.74-4 0.78-3 0.83-2 0.88-1 0.94 0 1 1 1.06 2 1.13 3 1.20 4 1.27

Calibration Procedure (SOP) Place the Ra-223 in the calibrator making sure it is centred in the measuring chamber Adjust the calibrator until it displays the decay corr activity A c Note the calibrator factor/setting for further measurements of unknown activity Perform 3 measurements with the Ra-223 standard source. Allow calibrator to return to bkgd between the measurements. All three measurements should be ± 5% of A c

Calibration Procedure (SOP) 5. References None 6. Revision First 7. Appendices Scheme 1 and Scheme 2

Calibrator at Velindre Capintec CRC15 Beta - consists of a chamber (for γ emitters) and a beta counter (for pure β emitters) - measurements of Ra-223 performed in the ionisation chamber

In practice! Receive vial of Ra-223 Activity (MBq) on date @ 1200 CET (no hours on decay chart so can only do approximate activity if measurements not made at this time) Our factor appeared to be between Cal #240 and Cal #250 (1 dec place)

In practice! Measurement repeated the following day at 12:00 (should have been 11:00!) Activity in vial calculated to 2 dec places using Vol Corr Chart. SPC button pressed to display 2 dec places on calibrator -factor then appeared to CAL #251 using the vial jig supplied with the calibrator.

Results Scheme 1-Decay correction of Ra-223 standard soln Stated Act (A) Calib date (std soln) Date of Calib of dose calib Decay corr act in std soln Ac= A x cf Ra-223 calib no/factor from vol corr table 6MBq 21.7.05 @12:00 13.7.05 @12:00 9.67MBq CAL #251

Results Scheme 2 Affirmative measurements Decay corrected Activity Activity Affirmative measurement 1 Activity Affirmative measurement 2 Activity Affirmative measurement 3 A c (MBq) (MBq) (MBq) (MBq) 9.67 9.62 9.60 9.76

In practice! Results faxed off to company no information ever received back if we were right or wrong despite me asking. As for syringe measurements. Every centre involved in the trial is using the same factor as derived for the vial. Our syringe jig drops activity down into calibrated part of the chamber. Purely go on volume dispensed. Vial activity means Ra- 223 solution in equilibrium, not necessarily the case for the syringe.

New Calibration SOP Purpose and Responsibility not changed much Definitions now defines a dose calibrator, sample calib date (prior to calib date the activity is higher than stated, after the activity is less), isotope calibration factor or number Procedure corr the std activity for decay according to the formula A c = A 0. e where ( - ln2 * d ) 11.43 A 0 is stated activity of the vial d = no of days (this number is below zero in the case where the dose calibrator dial setting is performed before the sample calibration date) Recording the measurements appears to be the same

New Calibration SOP References None Revision Second -changes from the first edition: The procedure for decay correction of the stated activity is converted from a correction based on a decay table to a direct decay correction by means of a standard decay formula for radioactive substance. Minor linguistic updates are performed. A user friendlier version of Scheme 1 and 2 is presented.